---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-24-001358"
form_type: "8-K"
ticker: "BBIO"
cik: "0001743881"
company_name: "BridgeBio Pharma, Inc."
filed_at: "2024-01-08T23:59:59+00:00"
generated_at: "2026-06-07T02:25:16.978214+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# BridgeBio Pharma presents business update at 42nd Annual J.P. Morgan Healthcare Conference

## Summary
- BridgeBio Pharma presented a business update at the 42nd Annual J.P. Morgan Healthcare Conference on January 8, 2024.
- The presentation slides were filed as Exhibit 99.1 to the Form 8-K and published on the company's website.
- The update was signed by CFO Brian C. Stephenson.

## SEC filing metadata
- accession: 0001140361-24-001358
- form_type: 8-K
- ticker: BBIO
- cik: 0001743881
- company_name: BridgeBio Pharma, Inc.
- filed_at: 2024-01-08T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1743881/000114036124001358/0001140361-24-001358-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1743881/000114036124001358/ef20018306_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-24-001358
- JSON: https://secwatch.observer/filing/0001140361-24-001358.json
- Plain text: https://secwatch.observer/filing/0001140361-24-001358.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.